Axial Spine and Sacroiliac Joint

  • Chapter
  • First Online:
Regenerative Medicine

Abstract

The use of biologics in the treatment of back pain is gaining rapid popularity due to their potential ability to repair and restore homeostasis. Several autologous and allogenic products are now available, although clinical data supporting their use remain limited. In this chapter, we will discuss the clinical applications of commonly used biologics, with an emphasis on autologous PRP and autologous MSCs. We will focus on their use in the treatment of the most common sources of pain in the lumbar spine, i.e., the intervertebral disks (IVDs), the facet joints, and the sacroiliac (SI) joints.

The objective of this chapter is to provide a basic overview of the available literature, concept, and guidelines for the safe and effective use of biologic therapy in the lumbar spine, with a focus on axial skeleton pain, including intervertebral disks (IVDs), facet joints, and sacroiliac (SI) joints.

We present an initial review of available biologics, as well as the biomechanics of the axial spine, followed by a comprehensive review and analysis of all published clinical studies in the field of regenerative medicine that are relevant to the topics that were reviewed and analyzed.

The discovery of biologics has prompted their consideration for alleviating pain and improving function, as well as for potentially restoring the normal structure of the spine. Additional high-quality studies are needed for deeper insight into the long-term safety and efficacy of regenerative medicine modalities pertinent to the spine.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
EUR 29.95
Price includes VAT (Germany)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
EUR 84.99
Price includes VAT (Germany)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
EUR 106.99
Price includes VAT (Germany)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info
Hardcover Book
EUR 106.99
Price includes VAT (Germany)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Navani A, Manchikanti L, Albers S, et al. Responsible, safe, and effective use of biologics in the management of low back pain: American Society of Interventional Pain Physicians (ASIPP) guidelines. Pain Physician. 2019;22:S1–S74.

    Article  Google Scholar 

  2. Dieleman JL, Squires E, Bui AL, Campbell M, Chapin A, Hamavid H, Horst C, Li Z, Matyasz T, Reynolds A, Sadat N, Schneider MT, Murray CJL. Factors associated with increase in US health care spending, 1996–2013. JAMA. 2017;318:1668–78.

    Article  Google Scholar 

  3. Conway PH. Editorial: factors associated with increased US health care spending. Implications for controlling health care costs. JAMA. 2017;318:1657–8.

    Article  Google Scholar 

  4. Tuakli-Wosornu YA, Terry A, Boachie-Adjei K, et al. Lumbar intradiscal platelet-rich plasma (PRP) injections: a prospective, double blind, randomized controlled. PM R. 2016;8(1):1–10.

    Article  Google Scholar 

  5. Monfett M, Harrison J, Boachie-Adjei K, Lutz G. Intradiscal platelet-rich plasma (PRP) injections for discogenic low back pain: an update. Int Orthop. 2016;40(6):1321–8.

    Article  Google Scholar 

  6. Akeda K, Ohishi K, Masuda K, et al. Intradiscal injection of autologous platelet-rich plasma releasate to treat discogenic low back pain: a preliminary clinical trial. Asian Spine J. 2017;11(3):380–9.

    Article  Google Scholar 

  7. Levi D, Horn S, Tyszko S, et al. Intradiscal platelet-rich plasma injection for chronic discogenic low back pain: preliminary results from a prospective trial. Pain Med. 2016;17(6):1010–22.

    PubMed  Google Scholar 

  8. Kirchner F, Anitua E. Intradiscal and intra-articular facet infiltrations with plasma rich in growth factors in patients with chronic low back pain. J Craniovertebr Junction Spine. 2016;7(4):250–6.

    PubMed  PubMed Central  Google Scholar 

  9. Navani A, Ambach M, Navani R, Wei J. Biologics for lumbar discogenic pain: 18-month follow up for safety and efficacy. Interv Pain Manag Rep. 2018;2(3):111–8.

    Google Scholar 

  10. Noriega DC, Adura F, Hernández-Ramajo R, Martín-Ferrero MA, Sánchez-Lite I, Toribio B, Alberca M, García V, Moraleda JM, Sánchez A, Garcia-Sancho J. Intervertebral disc repair by allogeneic mesenchymal bone marrow cells: a randomized controlled trial. Transplantation. 2017;10:1945–51.

    Article  Google Scholar 

  11. Pettine K, Suzuki R, Sand T, Murphy M. Treatment of discogenic back pain with autologous bone marrow concentrate injection with minimum two-year follow-up. Int Orthop. 2016;40:135–40.

    Article  Google Scholar 

  12. Coric D, Pettine K, Sumich A, Boltes MO. Prospective study of disc repair with allogeneic chondrocytes presented at the 2012 joint spine section meeting. J Neurosurg Spine. 2013;18:85–95.

    Article  Google Scholar 

  13. Orozco L, Soler R, Morera C, Alberca M, Sánchez A, García-Sancho J. Intervertebral disc repair by autologous mesenchymal bone marrow cells: a pilot study. Transplantation. 2011;92:822–8.

    Article  Google Scholar 

  14. Kumar H, Ha DH, Lee EJ, Park JH, Shim JH, Ahn TK, Kim KT, Ropper AE, Sohn S, Kim CH, Thakor DK, Lee SH, Han IB. Safety and tolerability of intradiscal implantation of combined autologous adipose-derived mesenchymal stem cells and hyaluronic acid in patients with chronic discogenic low back pain: 1-year follow-up of a phase I study. Stem Cell Res Ther. 2017;8:262.

    Article  CAS  Google Scholar 

  15. Mochida J, Sakai D, Nakamura Y, Watanabe T, Yamamoto Y, Kato S. Intervertebral disc repair with activated nucleus pulposus cell transplantation: a three-year, prospective clinical study of its safety. Eur Cell Mater. 2015;29:202–12.

    Article  CAS  Google Scholar 

  16. Meisel HJ, Ganey T, Hutton WC, Libera J, Minkus Y, Alasevic O. Clinical experience in cell based therapeutics: intervention and outcome. Eur Spine J. 2006;15:S397annular-S405.

    Google Scholar 

  17. Beall DP, Davis T, DePalma MJ, Amirdelfan K, Yoon ES, Wilson GL, Bishop R, Tally WC, Gershon SL, Lorio MP, Meisel HJ, Langhorst M, Ganey T, Hunter CW. Viable disc tissue allograft supplementation; one- and two-level treatment of degenerated intervertebral discs in patients with chronic discogenic low back pain: one year results of the VAST randomized controlled trial. Pain Physician. 2021;24(6):465–77. PMID: 34554689.

    Article  Google Scholar 

  18. Amirdelfan K, Bae H, McJunkin T, DePalma M, Kim K, Beckworth WJ, Ghiselli G, Bainbridge JS, Dryer R, Deer TR, Brown RD. Allogeneic mesenchymal precursor cells treatment for chronic low back pain associated with degenerative disc disease: a prospective randomized, placebo-controlled 36-month study of safety and efficacy. Spine J. 2021;21(2):212–30. https://doi.org/10.1016/j.spinee.2020.10.004. Epub 2020 Oct 9. PMID: 33045417.

    Article  PubMed  Google Scholar 

  19. Wu T, Song HX, Dong Y, Li J. Cell-based therapies for lumbar discogenic low back pain: systematic review and single-arm meta-analysis. Spine (Phila Pa 1976). 2018;43:49–57.

    Article  CAS  Google Scholar 

  20. Beall D, Wilson G, Bishop R, Tally W. VAST clinical trial: safely supplementing tissue lost to degenerative disc disease. Int J Spine Surg. 2020;14(2):239–53. https://doi.org/10.14444/7033.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Manchikanti L, Hirsch JA, Falco FJ, Boswell MV. Management of lumbar zygapophyseal (facet) joint pain. World J Orthop. 2016;7:315–37.

    Article  Google Scholar 

  22. Teichtahl AJ, Wluka AE, Wijethilake P, et al. Wolff’s law in action: a mechanism for early knee osteoarthritis. Arthritis Res Ther. 2015;1:17207.

    Google Scholar 

  23. Wu J, Zhou J, Liu C, Zhang J, **ong W, Lv Y, Liu R, Wang R, Du Z, Zhang G, Liu Q. A prospective study comparing platelet-rich plasma and local anesthetic (LA)/corticosteroid in intra-articular injection for the treatment of lumbar facet joint syndrome. Pain Pract. 2017;17:914–24.

    Article  Google Scholar 

  24. Wu J, Du Z, Lv Y, Zhang J, **ong W, Wang R, Liu R, Zhang G, Liu Q. A new technique for the treatment of lumbar facet joint syndrome using intra-articular injection with autologous platelet rich plasma. Pain Physician. 2016;19:617–25.

    Article  Google Scholar 

  25. Kirchner F, Anitua E. Intradiscal and intra-articular facet infiltrations with plasma rich in growth factors reduce pain in patients with chronic low back pain. J Craniovertebr Junction Spine. 2016;7:250–6.

    PubMed  PubMed Central  Google Scholar 

  26. Simopoulos TT, Manchikanti L, Gupta S, et al. Systematic review of the diagnostic accuracy and therapeutic effectiveness of sacroiliac joint interventions. Pain Physician. 2015;18:E713–56.

    Article  Google Scholar 

  27. Nagamoto Y, Iwasaki M, Sakaura H, et al. Sacroiliac joint motion in patients with degenerative lumbar spine disorders. J Neurosurg Spine. 2015;23(2):209–16.

    Article  Google Scholar 

  28. Ko GD, Mindra S, Lawson GE, et al. Case series of ultrasound-guided platelet- rich plasma injection for sacroiliac joint dysfunction. J Back Musculoskelet Rehabil. 2017;30(2):363–70.

    Article  Google Scholar 

  29. Singla V, Batra YK, Bharti N, Goni VG, Marwaha N. Steroid vs. platelet-rich plasma in ultrasound-guided sacroiliac joint injection for chronic low back pain. Pain Pract. 2017;17:782–91.

    Article  Google Scholar 

  30. Navani A, Gupta D. Role of intra-articular platelet-rich plasma in sacroiliac joint pain. Reg Anesth Pain Med. 2015;19:54–9.

    Google Scholar 

  31. Lin C-S, Lin G, Lue TF. Allogenic and xenogenetic transplantation of adipose- derived stem cells in immunocompetent recipients without immunosuppressants. Stem Cells Dev. 2012;21(15):2770–8.

    Article  Google Scholar 

  32. O’Donoghue K, Fisk NM. Fetal stem cells. Best Pract Res Clin Obstet Gynaecol. 2004;18(6):835–75.

    Google Scholar 

  33. Wang Y, Zhao S. Vascular biology of the placenta. San Rafael: Morgan and Claypool Life Sciences; 2010.

    Book  Google Scholar 

  34. Rodolfa K, di Giorgio FP, Sullivan S. Defined reprogramming: a vehicle for changing the differentiated state. Differentiation. 2007;75(7):577–9.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Annu Navani .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Navani, A., Chrystal, J. (2023). Axial Spine and Sacroiliac Joint. In: Hunter, C.W., Davis, T.T., DePalma, M.J. (eds) Regenerative Medicine . Springer, Cham. https://doi.org/10.1007/978-3-030-75517-1_24

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-75517-1_24

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-75516-4

  • Online ISBN: 978-3-030-75517-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Navigation